Hypercholesterolemia. The evidence supports use of statins
- PMID: 12938249
Hypercholesterolemia. The evidence supports use of statins
Abstract
Using statins to treat older men and women with coronary artery disease (CAD) and hypercholesterolemia reduces the risk of all-cause mortality, cardiovascular mortality, coronary events, coronary revascularization, stroke, Intermittent claudication, and congestive heart failure. The target serum low-density lipoprotein (LDL) cholesterol level is < 100 mg in older patients with CAD, prior stroke, peripheral arterial disease, extracranial carotid arterial disease, abdominal aortic aneurysm, diabetes meilitus, and the metabolic syndrome. Statins are also effective in reducing cardiovascular events in older persons with hypercholesterolemia without cardiovascular disease. Consider using statins in older persons without cardiovascular disease but with a serum LDL cholesterol > or = 130 mg/dL, or a serum high-density lipoprotein cholesterol < 50 mg/dL. Data from the Heart Protection Study favor treating patients at high risk for vascular events with statins regardless of age or initial serum lipids.
Similar articles
-
Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD.Geriatrics. 2001 Sep;56(9):22-5, 28-30. Geriatrics. 2001. PMID: 11582971 Review.
-
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.Eur Heart J. 2004 May;25(9):771-7. doi: 10.1016/j.ehj.2004.03.013. Eur Heart J. 2004. PMID: 15120888 Clinical Trial.
-
Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.Ann Pharmacother. 2007 Sep;41(9):1345-51. doi: 10.1345/aph.1K140. Epub 2007 Jul 31. Ann Pharmacother. 2007. PMID: 17666579 Clinical Trial.
-
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002. Am J Geriatr Pharmacother. 2007. PMID: 17996658
-
Lipid management with statins. The lower the better?Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y. Z Kardiol. 2004. PMID: 14740235 Review.
Cited by
-
Effect of Atorvastatin on Serum Para-Oxonase-1 and C-Reactive Protein in Wistar Rats.Indian J Clin Biochem. 2019 Jul;34(3):312-317. doi: 10.1007/s12291-018-0742-1. Epub 2018 Mar 17. Indian J Clin Biochem. 2019. PMID: 31391721 Free PMC article.
-
Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates.J Biomed Biotechnol. 2004;2004(4):177-184. doi: 10.1155/S1110724304311010. J Biomed Biotechnol. 2004. PMID: 15467157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous